In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cytomel Drug Master File in Korea (Cytomel KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cytomel. The MFDS reviews the Cytomel KDMF as part of the drug registration process and uses the information provided in the Cytomel KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cytomel KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cytomel API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cytomel suppliers with KDMF on PharmaCompass.